Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 14534-14535 [2022-05429]
Download as PDF
<![CDATA[
14534
Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices
You may submit comments
by mail to: Sherri Diana, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
34, Cincinnati, Ohio 45226.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
Written comments received in
advance of the meeting will be included
in the official record of the meeting. The
public is also welcomed to listen to the
meeting by joining the audio conference
(information below). The audio
conference line has 150 ports for callers.
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone:
(513) 533–6800, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
13889 on March 22, 2020, and will
terminate on March 22, 2022.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
21:10 Mar 14, 2022
Jkt 256001
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Set 30, possibly
including cases involving the Hanford
site and discussion of changes in SDRR
selection criteria based on SC&A
document, ‘‘Summary Dose
Reconstruction Information,’’ dated
December 20, 2021. Agenda items are
subject to change as priorities dictate.
For additional information, please
contact Toll Free 1 (800) CDC–INFO.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–05428 Filed 3–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC). This is a
virtual meeting and is open to the
public, limited by the capacity of the
SUMMARY:
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
conference webinar which is 2,000
participants. Pre-registration is required.
Time will be available for public
comment.
DATES: The meeting will be held on
April 11, 2022, from 10:00 a.m. to 4:30
p.m., EDT. The public may submit
written comments from March 15, 2022
through April 18, 2022.
ADDRESSES: Zoom Virtual Meeting. If
you would like to attend the virtual
meeting, please pre-register by accessing
the link at https://
dceproductions.zoom.us/webinar/
register/WN_Mi3IYbnQTOmu
EKZBxScBWQ. Instructions to access
the Zoom virtual meeting will be
provided in the link following
registration.
Meeting Information: There will be a
public comment period from 3:45 p.m.–
4:15 p.m., EDT. The public is
encouraged to register for the BSC,
NCIPC April 11, 2022, meeting public
comment period by accessing the link
provided: https://
www.surveymonkey.com/r/l3hdzb6.
Individuals wishing to pre-register for
public comment must do so by
Wednesday, April 6, 2022, at 5:00 p.m.,
EDT.
FOR FURTHER INFORMATION CONTACT:
Arlene Greenspan, DrPH, MPH, PT,
Associate Director for Science, National
Center for Injury Prevention and
Control, Centers for Disease Control and
Prevention, 4770 Buford Highway NE,
Mailstop S106–9, Atlanta, Georgia
30341, Telephone: (770) 488–1279;
Email address: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of injury and violence,
and other impairments; (2) assist States
and their political subdivisions in
preventing intentional and
unintentional injuries and to promote
health and well-being; and (3) conduct
and assist in research and control
activities related to injury. The Board of
Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury
prevention goals and provides evidence
in injury prevention-related research
and programs. In addition, the Board
provides advice on the appropriate
balance of intramural and extramural
research, the structure, progress, and
performance of intramural programs.
E:\FR\FM\15MRN1.SGM
15MRN1
Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
The Board is designed to provide
guidance on extramural scientific
program matters, including the: (1)
Review of extramural research concepts
for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to the funding opportunity
announcements as it relates to the
Center’s programmatic balance and
mission; (3) submission of secondary
review recommendations to the Center
Director of applications to be considered
for funding support; (4) review of
research portfolios, and (5) review of
program proposals.
Matters To Be Considered: The agenda
will include an update on the Traumatic
Brain Injury (TBI) Research Priorities;
Older Adult Falls Research Priorities;
the Diversity, Equity, Belonging,
Inclusion and Accessibility (DEBIA)
Strategic Plan; and Health Equity.
Agenda items are subject to change as
priorities dictate.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Clinical Laboratory Improvement
Advisory Committee (CLIAC)
Public Participation
Written Public Comment: Written
comments must be received on or before
5:00 p.m., EDT, April 18, 2022, by email
at ncipcbsc@cdc.gov. All written
comments will be included as part of
the meeting minutes.
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment.
Individuals wishing to pre-register for
public comment must do so by
Wednesday, April 6, 2022, at 5:00 p.m.,
EDT. Those pre-registering for public
comment must also register for the
meeting using the link below.
Oral Public Comment Procedure:
Individuals registered to provide public
comment will be called upon first to
speak based on the order of registration,
followed by others from the public. All
public comments will be limited to two
(2) minutes per speaker.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
SIP22–007, COVID–19 and Women: An
Assessment of Challenges and Lessons
Learned to Enhance Public Health
Emergency Preparedness for Women
and Families.
Date: May 11, 2022
Time: 11:00 a.m.–6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
National Center for Chronic Disease
Prevention and Health Promotion, CDC,
4770 Buford Highway, Mailstop S107–
B, Atlanta, Georgia 30341, Telephone:
(770) 488–6511, Email: JRaman@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–05429 Filed 3–14–22; 8:45 am]
[FR Doc. 2022–05431 Filed 3–14–22; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
VerDate Sep<11>2014
21:10 Mar 14, 2022
Jkt 256001
14535
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Clinical Laboratory Improvement
Advisory Committee (CLIAC). This
meeting is open to the public, limited
only by the webcast lines available.
Check the CLIAC website on the day of
the meeting for the web conference link
https://www.cdc.gov/cliac. Time will be
available for public comment.
DATES: The meeting will be held on
April 13, 2022, from 11:00 a.m. to 6:00
p.m., EDT, and April 14, 2022, from
11:00 a.m. to 6:00 p.m., EDT.
ADDRESSES: This is a virtual meeting.
Meeting times are tentative and subject
to change. The confirmed meeting
times, agenda items, and meeting
materials including instructions for
accessing the live meeting broadcast
will be available on the CLIAC website
at https://www.cdc.gov/cliac.
FOR FURTHER INFORMATION CONTACT:
Nancy Anderson, MMSc, MT(ASCP),
Senior Advisor for Clinical Laboratories,
Division of Laboratory Systems, Center
for Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop V24–3,
Atlanta, Georgia 30329–4018,
Telephone: (404) 498–2741;
NAnderson@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Committee is charged
with providing scientific and technical
advice and guidance to the Secretary,
HHS; the Assistant Secretary for Health;
the Director, CDC; the Commissioner,
Food and Drug Administration (FDA);
and the Administrator, Centers for
Medicare and Medicaid Services (CMS).
The advice and guidance pertain to
general issues related to improvement in
clinical laboratory quality and
laboratory medicine practice and
specific questions related to possible
revision of the Clinical Laboratory
Improvement Amendments of 1988
(CLIA) standards. Examples include
providing guidance on studies designed
to improve safety, effectiveness,
efficiency, timeliness, equity, and
SUMMARY:
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 87, Number 50 (Tuesday, March 15, 2022)]
[Notices]
[Pages 14534-14535]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05429]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC). This
is a virtual meeting and is open to the public, limited by the capacity
of the conference webinar which is 2,000 participants. Pre-registration
is required. Time will be available for public comment.
DATES: The meeting will be held on April 11, 2022, from 10:00 a.m. to
4:30 p.m., EDT. The public may submit written comments from March 15,
2022 through April 18, 2022.
ADDRESSES: Zoom Virtual Meeting. If you would like to attend the
virtual meeting, please pre-register by accessing the link at https://dceproductions.zoom.us/webinar/register/WN_Mi3IYbnQTOmuEKZBxScBWQ.
Instructions to access the Zoom virtual meeting will be provided in the
link following registration.
Meeting Information: There will be a public comment period from
3:45 p.m.-4:15 p.m., EDT. The public is encouraged to register for the
BSC, NCIPC April 11, 2022, meeting public comment period by accessing
the link provided: https://www.surveymonkey.com/r/l3hdzb6. Individuals
wishing to pre-register for public comment must do so by Wednesday,
April 6, 2022, at 5:00 p.m., EDT.
FOR FURTHER INFORMATION CONTACT: Arlene Greenspan, DrPH, MPH, PT,
Associate Director for Science, National Center for Injury Prevention
and Control, Centers for Disease Control and Prevention, 4770 Buford
Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, Telephone: (770)
488-1279; Email address: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of injury and
violence, and other impairments; (2) assist States and their political
subdivisions in preventing intentional and unintentional injuries and
to promote health and well-being; and (3) conduct and assist in
research and control activities related to injury. The Board of
Scientific Counselors makes recommendations regarding policies,
strategies, objectives, and priorities; and reviews progress toward
injury prevention goals and provides evidence in injury prevention-
related research and programs. In addition, the Board provides advice
on the appropriate balance of intramural and extramural research, the
structure, progress, and performance of intramural programs.
[[Page 14535]]
The Board is designed to provide guidance on extramural scientific
program matters, including the: (1) Review of extramural research
concepts for funding opportunity announcements; (2) conduct of
Secondary Peer Review of extramural research grants, cooperative
agreements, and contracts applications received in response to the
funding opportunity announcements as it relates to the Center's
programmatic balance and mission; (3) submission of secondary review
recommendations to the Center Director of applications to be considered
for funding support; (4) review of research portfolios, and (5) review
of program proposals.
Matters To Be Considered: The agenda will include an update on the
Traumatic Brain Injury (TBI) Research Priorities; Older Adult Falls
Research Priorities; the Diversity, Equity, Belonging, Inclusion and
Accessibility (DEBIA) Strategic Plan; and Health Equity. Agenda items
are subject to change as priorities dictate.
Public Participation
Written Public Comment: Written comments must be received on or
before 5:00 p.m., EDT, April 18, 2022, by email at [email protected].
All written comments will be included as part of the meeting minutes.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Individuals wishing to pre-register
for public comment must do so by Wednesday, April 6, 2022, at 5:00
p.m., EDT. Those pre-registering for public comment must also register
for the meeting using the link below.
Oral Public Comment Procedure: Individuals registered to provide
public comment will be called upon first to speak based on the order of
registration, followed by others from the public. All public comments
will be limited to two (2) minutes per speaker.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05429 Filed 3-14-22; 8:45 am]
BILLING CODE 4163-18-P
